| Dr Edmond Olatunde Alaka, MD | |
|
100 N Main St, Chattahoochee, FL 32324 | |
| (850) 663-7661 | |
| Not Available |
| Full Name | Dr Edmond Olatunde Alaka |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 100 N Main St, Chattahoochee, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902193758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | ME109501 (Florida) | Primary |
| Entity Name | Florida Department Of Children And Families |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710945118 PECOS PAC ID: 5092613570 Enrollment ID: O20031222000351 |
News Archive
Issues surrounding gender identity in young children who are transgender or gender non-conforming are poorly understood because of the limited amount of research in this area.
Non-obstructive coronary artery disease was associated with a 28 to 44 percent increased risk of a major adverse cardiac event such as a heart attack or death, in a new study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.
NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.
Genzyme Corporation today announced that it has entered into an asset purchase agreement under which Laboratory Corporation of America Holdings (LabCorp) will acquire Genzyme Genetics for $925 million in cash.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edmond Olatunde Alaka, MD 216 Elm Drive, Chattahoochee, FL 32324 Ph: (661) 713-7860 | Dr Edmond Olatunde Alaka, MD 100 N Main St, Chattahoochee, FL 32324 Ph: (850) 663-7661 |
News Archive
Issues surrounding gender identity in young children who are transgender or gender non-conforming are poorly understood because of the limited amount of research in this area.
Non-obstructive coronary artery disease was associated with a 28 to 44 percent increased risk of a major adverse cardiac event such as a heart attack or death, in a new study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.
NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.
Genzyme Corporation today announced that it has entered into an asset purchase agreement under which Laboratory Corporation of America Holdings (LabCorp) will acquire Genzyme Genetics for $925 million in cash.
› Verified 7 days ago
Adel S Bassel, M.D General Practice Medicare: Not Enrolled in Medicare Practice Location: 221 Flowerwood Dr, Chattahoochee, FL 32324 Phone: 850-228-3547 | |
Dr. Ceres Lim Roxas, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 100 N Main St, Chattahoochee, FL 32324 Phone: 850-663-7501 Fax: 850-663-7771 |